These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

776 related articles for article (PubMed ID: 25649017)

  • 1. The therapeutic potential of cannabinoids for movement disorders.
    Kluger B; Triolo P; Jones W; Jankovic J
    Mov Disord; 2015 Mar; 30(3):313-27. PubMed ID: 25649017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endocannabinoid system as a target for the treatment of motor dysfunction.
    Fernández-Ruiz J
    Br J Pharmacol; 2009 Apr; 156(7):1029-40. PubMed ID: 19220290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoids in movement disorders.
    Kluger BM; Huang AP; Miyasaki JM
    Parkinsonism Relat Disord; 2022 Sep; 102():124-130. PubMed ID: 36038457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoids and neuroprotection in motor-related disorders.
    de Lago E; Fernández-Ruiz J
    CNS Neurol Disord Drug Targets; 2007 Dec; 6(6):377-87. PubMed ID: 18220777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?
    Arjmand S; Vaziri Z; Behzadi M; Abbassian H; Stephens GJ; Shabani M
    Neurotherapeutics; 2015 Oct; 12(4):778-87. PubMed ID: 26152606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoids and basal ganglia functionality.
    Fernández-Ruiz J; Lastres-Becker I; Cabranes A; González S; Ramos JA
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):257-67. PubMed ID: 12052041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of cannabinoids as neuroprotective agents for damaged cells conducing to movement disorders.
    Antonazzo M; Botta M; Bengoetxea H; Ruiz-Ortega JÁ; Morera-Herreras T
    Int Rev Neurobiol; 2019; 146():229-257. PubMed ID: 31349929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection.
    More SV; Choi DK
    Mol Neurodegener; 2015 Apr; 10():17. PubMed ID: 25888232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid control of motor function at the basal ganglia.
    Fernández-Ruiz J; Gonzáles S
    Handb Exp Pharmacol; 2005; (168):479-507. PubMed ID: 16596785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects.
    Romero J; Lastres-Becker I; de Miguel R; Berrendero F; Ramos JA; Fernández-Ruiz J
    Pharmacol Ther; 2002 Aug; 95(2):137-52. PubMed ID: 12182961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cannabinoids in neurodegenerative diseases.
    Glass M
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 May; 25(4):743-65. PubMed ID: 11383976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….
    Baron EP
    Headache; 2015 Jun; 55(6):885-916. PubMed ID: 26015168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoids: novel medicines for the treatment of Huntington's disease.
    Sagredo O; Pazos MR; Valdeolivas S; Fernandez-Ruiz J
    Recent Pat CNS Drug Discov; 2012 Apr; 7(1):41-8. PubMed ID: 22280340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis, Cannabinoids, and Cerebral Metabolism: Potential Applications in Stroke and Disorders of the Central Nervous System.
    Latorre JG; Schmidt EB
    Curr Cardiol Rep; 2015 Sep; 17(9):627. PubMed ID: 26238742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic potential of the cannabinoids in neuroprotection.
    Grundy RI
    Expert Opin Investig Drugs; 2002 Oct; 11(10):1365-74. PubMed ID: 12387700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids: mechanisms and therapeutic applications in the CNS.
    Drysdale AJ; Platt B
    Curr Med Chem; 2003 Dec; 10(24):2719-32. PubMed ID: 14529462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids: Medical implications.
    Schrot RJ; Hubbard JR
    Ann Med; 2016; 48(3):128-41. PubMed ID: 26912385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen and movement disorders.
    Kompoliti K
    Clin Neuropharmacol; 1999; 22(6):318-26. PubMed ID: 10626091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.